Russia’s flagship two-shot vaccine Sputnik V has shown 91.6 per cent efficacy against symptomatic Covid-19 in clinical trials, a Lancet peer review has confirmed, bringing the global total of vaccines whose efficacy is confirmed to be higher than 90 per cent to three.
經《柳葉刀》(Lancet)同行評審確認，俄羅斯的旗艦疫苗、需要接種兩劑的“衛星-V”(Sputnik V)在臨床試驗中對預防有癥狀新型冠狀病毒肺炎（COVID-19，即2019冠狀病毒?。┑挠行蔬_到91.6%，從而使全球有效率經確認高于90%的疫苗總數增加到三種。
您已閱讀9%（402字），剩余91%（4082字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。